Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) CEO John Kao sold 298,000 shares of the stock in a transaction on Friday, July 10th. The stock was sold at an average price of $19.86, for a total transaction of $5,918,280.00. Following the transaction, the chief executive officer directly owned 1,088,766 shares in the company, valued at approximately $21,622,892.76. This represents a 21.49% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Alignment Healthcare Trading Up 4.0%
NASDAQ:ALHC opened at $21.20 on Wednesday. Alignment Healthcare, Inc. has a 12 month low of $11.63 and a 12 month high of $25.12. The company has a current ratio of 1.58, a quick ratio of 1.58 and a debt-to-equity ratio of 1.56. The stock has a market capitalization of $4.38 billion, a price-to-earnings ratio of 235.56, a PEG ratio of 2.75 and a beta of 1.05. The firm has a fifty day simple moving average of $19.09 and a two-hundred day simple moving average of $19.81.
Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last announced its quarterly earnings data on Thursday, April 30th. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of $0.01 by $0.04. The firm had revenue of $1.24 billion for the quarter, compared to analyst estimates of $1.22 billion. Alignment Healthcare had a net margin of 0.47% and a return on equity of 11.50%. The business's quarterly revenue was up 33.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned ($0.05) earnings per share. Analysts expect that Alignment Healthcare, Inc. will post 0.2 EPS for the current fiscal year.
Analyst Ratings Changes
A number of research firms recently weighed in on ALHC. Wolfe Research assumed coverage on Alignment Healthcare in a research note on Friday, April 17th. They set an "outperform" rating and a $24.00 price target on the stock. Raymond James Financial set a $22.00 price objective on Alignment Healthcare in a report on Thursday, May 7th. Barclays lowered their target price on Alignment Healthcare from $19.00 to $16.00 and set an "equal weight" rating on the stock in a research report on Tuesday, May 26th. KeyCorp reiterated an "overweight" rating on shares of Alignment Healthcare in a report on Wednesday, June 10th. Finally, Weiss Ratings raised shares of Alignment Healthcare from a "sell (d-)" rating to a "hold (c-)" rating in a research report on Thursday, May 7th. Six investment analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $24.30.
View Our Latest Report on ALHC
Institutional Investors Weigh In On Alignment Healthcare
A number of institutional investors and hedge funds have recently made changes to their positions in ALHC. Summit Securities Group LLC acquired a new position in Alignment Healthcare during the 4th quarter valued at about $26,000. Versant Capital Management Inc raised its stake in shares of Alignment Healthcare by 463.3% in the second quarter. Versant Capital Management Inc now owns 1,380 shares of the company's stock worth $33,000 after purchasing an additional 1,135 shares during the last quarter. Parallel Advisors LLC raised its stake in shares of Alignment Healthcare by 87.7% in the fourth quarter. Parallel Advisors LLC now owns 1,654 shares of the company's stock worth $33,000 after purchasing an additional 773 shares during the last quarter. Larson Financial Group LLC bought a new position in shares of Alignment Healthcare in the third quarter valued at approximately $33,000. Finally, First Horizon Corp bought a new position in shares of Alignment Healthcare in the fourth quarter valued at approximately $39,000. Institutional investors and hedge funds own 86.19% of the company's stock.
About Alignment Healthcare
(
Get Free Report)
Alignment Healthcare, Inc (NASDAQ: ALHC) is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.
At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
